Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -3,26 % | -6,49 % | -3,87 % | -28,73 % | -27,56 % | - | - |
| Healthequity Inc. | 0,76 % | 0,00 % | 7,26 % | -22,22 % | -14,74 % | 14,66 % | 3,10 % |
| Omnicell Inc. | 0,66 % | -14,61 % | -0,65 % | 2,70 % | -21,65 % | -37,45 % | -72,36 % |
| Myriad Genetics | 0,00 % | -5,45 % | 11,23 % | -54,03 % | -21,51 % | -79,11 % | -83,89 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




